Headlands Technologies’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$25.8K	Buy	+1,847	New	+$25.8K	﹤0.01%	891
2024 Q2	–	Sell	-4,295	Closed	-$88.1K	–	1237
2024 Q1	$88.1K	Buy	+4,295	New	+$88.1K	0.02%	572